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A detailed understanding of asymptomatic chronic viral infections is critical to analyse their patho-
genesis, assess the severity and burden of disease and, where required, optimize public health control
measures. Recent studies on herpesviruses showed that the hostevirus interactions are modulated by co-
infections, emphasizing the relevance of co-infections in determining the clinical expression (from
asymptomatic to symptomatic infections) and the severity of herpesvirus-associated diseases (either
neoplastic or infectious diseases). To demonstrate causality between viruses (virome) and diseases,
Koch's postulates should be adapted adding new knowledge on hostemicrobe relationship and microbial
interactions. In the present review we aim to provide an update on asymptomatic chronic infections and
criteria for causality and on the virological, immunological and hostevirus interactions in asymptomatic
chronic infections in human hosts, focusing on herpetic infections. G. Gentile, CMI 2016;22:585
© 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Asymptomatic, chronic viral infections occur in a large portion
of humanity. It has been estimated that on average every human
being can be concurrently infected with 8e12 chronic viral in-
fections, caused either by DNA or RNA viruses [1]. Viruses consid-
ered to be commensal and opportunistic pathogens are
widespread, especially in adults, and include members of the
herpesvirus, adenovirus, papillomavirus, anellovirus, polyomavirus
and circovirus families [2,3]. Conversely, viruses associated with
high morbidity and mortality such as hepatitis C virus, hepatitis B
virus and human immunodeficiency virus (HIV) chronically infect
millions of individuals [4].
Until a few years ago, the approaches applied to studying host
immunity and viral virulence were mainly based on the analysis of
symptomatic acute infections, and evaluated virus shedding and
serological evidence of infection, together with the analysis of the
immune responses of the host. Studies of acute infections have
been relevant for analysing viral virulence and host immunity;
however, the mechanisms that establish and perpetuate chronicCellular Biotechnologies and
00161, Rome, Italy.
e).
biology and Infectious Diseases. Puviral infections are still not well known [1]. These mechanisms can
be analysed taking into account the behaviour of a component of
the microbiome, the virome. The microbiome, defined as all the
microorganisms (viruses, bacteria, parasites and fungi) living
within a human host, is a component of human physiology [5],
while the virome is part of the microbiome of healthy humans, and
includes the viruses (pathogenic and non-pathogenic) that infect
the eukaryotic cells of the host, those that replicate in bacteria
(bacteriophages or phages) and the endogenous viral elements [6].
A new and emerging concept includes the view that viruses may
have deleterious or beneficial immunomodulatory effects other
than affecting the adaptive and innate immune response [7,8]. For
instance, recent studies on herpesviruses clearly evidenced that the
hostevirus interactions are modulated by co-infections (reviewed
in refs [9e11]), emphasizing the relevance of co-infections in
determining the clinical expression (from asymptomatic to symp-
tomatic infections) and the severity of herpesvirus-associated dis-
eases (either neoplastic or infectious diseases), such as those
induced by EpsteineBarr virus (EBV) and human herpesvirus 8
(HHV-8) [9,11].
For two centuries, Koch's postulates were the landmark for
establishing causation in infectious diseases. In recent years, Koch's
postulates have beenmodified to take into account new knowledge
of the hostemicrobe relationship and microbial interactions by
means of genome sequencing. Therefore, it has been proposed toblished by Elsevier Ltd. All rights reserved.
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advances in technology [12].
An understanding of asymptomatic chronic viral infections,
defined as infections without any sign or symptom, is important for
understanding the pathogenesis of viral infections, assessing their
severity and the burden of disease and, where required, for opti-
mizing public health control measures. It is important to recognize
that the study of asymptomatic chronic viral infections is an
emerging field, and part of our discussion will necessarily be
speculative. Specifically, our goal is to provide an update on
asymptomatic chronic infections and criteria for causality and
about the virological, immunological and hostevirus interactions in
asymptomatic chronic infections in human hosts, focusing on
herpetic infections. Due to space constraints, we will focus our
review mainly on EBV and HHV-8 infections because, in our
opinion, they represent the paradigm of chronic asymptomatic
infections. They are well-known viruses, but recent studies showed
that the hostevirus interactions are modulated by some co-
infections, greatly expanding our knowledge in the general field
of chronic viral infections.
Asymptomatic chronic infections and criteria for causality
The criteria commonly used to assign causality in medical
research, especially by infectious diseases physicians, are the Koch
postulates [13]. The criteria were partially redefined by Jacob Henle
in 1840 [14] and later expanded and referred to as the HenleeKoch
postulates [15]. These postulates state that: (a) the organism is al-
ways present in every case of the disease in question and under
circumstances that can account for the pathological changes and
clinical course of the disease; (b) the organism is not found with
any other disease or as a colonizer without disease; (c) after being
isolated from the body and repeatedly grown in pure culture, the
organism reproduces the disease again in an another susceptible
host. The main problem concerning the application of the Hen-
leeKoch postulates is linked to the impossibility of applying them
to themajority of pathogens and in particular to viruses. As obligate
cellular parasites, viruses cannot be formally evaluated in pure
culture; for example cells that become cancer cells due to viral
infections are non-permissive for viral replication, and therefore
virions are not identifiable, and in these conditions Koch's postu-
lates are not applicable.
The culture-dependent approaches could not demonstrate the
role of the association between infectious agents, mainly viruses,
and chronic or neoplastic diseases. Two significant examples show
the long latency period between a primary viral infection (often
asymptomatic or subclinical) and the occurrence of a disease: hu-
man T lymphotropic virus-1-associated myelopathy/tropical spas-
tic paraparesis or T-cell leukaemia following T-lymphotropic virus
type 1 decades after the primary infection (reviewed in ref. [16])
and Kaposi sarcoma (KS) following Kaposi's sarcoma-associated
herpesvirus (KSHV, also called HHV-8) (reviewed in ref. [16]).
Hill's criteria (strength of association, consistency, specificity,
temporality, biological gradient, plausibility, coherence, experi-
ment, analogy) are now used to determine causality for infectious
microorganisms in chronic or neoplastic diseases [17]. However,
again the strict application of Hill's criteria or HenleeKoch postu-
lates may not be able to identify the causal role of viruses in the
aetiology of infectious diseases or tumours [18,19]. The high-
throughput deep sequencing assays, together with bioinformatics
systems, have revolutionized the studies on microbial commu-
nities, providing useful tools for assigning causality between mi-
croorganisms and infectious diseases. At present two main
methods are applied: (a) the bacterial 16S ribosomal gene profile
analysis, used to study bacterial phylogeny and taxonomy, whichallows determination of the relative abundance of each species in a
given sample; (b) the next-generation sequencing or ‘shotgun’
metagenomic sequencing, which uses a direct sequencing of total
DNA and examines also viral sequences, allowing the detection of a
broad range of both cultivable and non-cultivable DNA viruses
[20,21]. Metagenomic studies applied to viruses provide a signifi-
cant insight into identification and characterization of new viruses,
on viruses associated with diseases of unknown aetiology, molec-
ular epidemiology, molecular pathogenesis, genome characteriza-
tion, gene discovery with genetic diversity, and on dynamics of
microbial populations, focusing primarily on the interaction be-
tween viruses and host immune system [22,23]. However, a present
limitation of the metagenomic studies applied to viruses is that the
detection of DNA viral sequences in a given sample does not
formally demonstrate that the viruses found are replicating.
Therefore, future studies should be focused on active viral in-
fections by assessing, for instance, cell-free virus particles and on
analyses and sequencing of RNA viruses [6]. With the intention of
avoiding a reductionist methodological approach it will be impor-
tant to perform, in addition to the metagenomic studies, also
metatranscriptomic (analyses of messenger viral RNA) together
with metaproteomic (analyses of expressed proteins) studies [24],
allowing a better comprehension of the pathways and community
interactions of the viruses and their role in the asymptomatic and
symptomatic infections.
Herpesviruses: paradigm of chronic asymptomatic infections
Herpesviruses are ubiquitous viruses, infect a high number of
subjects with a variable worldwide distribution, and it is estimated
that >90% of humans are infected with at least one herpesvirus [1].
For example, primary cytomegalovirus (CMV), human herpesvirus-
6 and EBV infections usually occur more frequently during the first
two decades of life as asymptomatic infections or symptomatic
mononucleosis-like syndrome [25e27]. Herpesviruses may also
cause several forms of diseases in humans, and in particular, HHV-8
and EBV are associated with several tumours: HHV-8 with KS and
lymphoproliferative diseases [16], and EBV with lymphomas and
nasopharyngeal carcinomas [16].
Reactivation of herpesviruses from latency is required for the
viruses to persist and to spread among cells and host. Environ-
mental conditions induce herpesviruses to switch from latency to
lytic phases [28], but the mechanisms by which these stimuli
function in vivo have not been elucidated. Short-chain and
medium-chain fatty acids found in the diet or produced by human
microbiota may modulate the balance between the latent and lytic
phases of both EBV and HHV-8, showing that an interaction be-
tween bacteria and virome may affect herpesvirus activation [29].
Epigenetic alterations may stimulate lytic reactivation, productions
of virions and spread of herpesviruses [30]. In particular, HHV-8
and EBV are probably regulated by epigenetic modifications
induced by bacteria [31,32] and it is possible to speculate that
bacteriumevirus interactions might contribute to the pathogenesis
of cancers such as KS and gastric cancers associated with Heli-
cobacter pylori and EBV [30].
Chronic herpesviruses infections induce a modulation of the
host immune defences, which in turn promote immune suppres-
sion and a greater susceptibility to infections. For example,
asymptomatic chronic infections with CMV and human
herpesvirus-6 are able to reduce or to alter the immune response
through various mechanisms and in specific clinical settings, such
as solid organ or haematopoietic stem cell transplants. These
chronic infections may be associated with the development of
secondary clinically relevant infections due to fungi, bacteria and/
or other viruses other than allograft rejection and with decreased
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have shown that a chronic asymptomatic herpesvirus infection,
being a physiological viroma constituent, may have a surprisingly
protective effect on the host against viral and bacterial infections
[36]. For example, latent murine g-herpesvirus 68 infection might
prevent the development of tumours [37], and might increase the
resistance to Listeria monocytogenes and Yersinia pestis [36]; in
addition, asymptomatic CMV infection may have a beneficial effect
on the immune responses to influenza virus of younger human
adults [38], showing that herpesvirus latency may be a symbiotic
relationship with immune benefits for the host. In addition, an
interplay between bacteria and CMV has been shown by studying
the relationship between experimental inflammatory bowel dis-
ease in mice, murine CMV infection and commensal Gram-negative
and anaerobic bacterial antigens; it was found that murine CMV
infection might have increased colitis by altering the intestinal
immune response to gut microbiome [39].
EBV co-infection with malaria
It remains unclear why some individuals infected with EBV
develop infectious mononucleosis and others do not. Acute symp-
tomatic infectious mononucleosis, is more frequently observed
during adolescence or later in life in Western countries [40]. On the
contrary, children in sub-Saharan Africa have the primary infection
within the first years of life, mainly by 12 months of age and are
typically asymptomatic [41].
Primary infection acquired at an early age or in addition with a
co-infection can induce poor control of EBV replication and might
be a risk factor for the development of subsequent chronic diseases,
including cancer. For example, EBV and malaria co-infections have
been associated with the development of endemic Burkitt lym-
phoma (eBL) [42], a common endemic childhood malignancy in
Africa, rapidly fatal if not treated. On the contrary, the impact of
acute EBV on the immunity to Plasmodium falciparum infections
and on malarial disease severity have not been fully evaluated [43].
Malaria infects about 200 million people worldwide and approxi-
mately 700 000 individuals die every year, mainly children under 5
years of age [44]. In this regard, HIV-negative infants living in re-
gions with high malaria exposure were infected with EBV earlier in
life, and young age at the time of infection (before 6 months of age)
led to frequent EBV detection and higher EBV loads [41], supporting
de-The's hypothesis [45] that young age at the time of asymp-
tomatic EBV infection might be a risk factor for the development of
eBL [41]. A recent longitudinal study confirmed the impact of
Plasmodium falciparum co-infection on EBV replication in Kenyan
children [46]. BL is characterized by chromosome translocation
between the c-myc oncogene and immunoglobulin gene loci, which
deregulates c-myc but is not sufficient by itself to induce lymphoma
[47]. Plasmodium infection alone does not induce cancer, and other
transforming events such as an EBV infection or other unknown
mechanisms are required. In this regard, the first evidence of a
mechanism to explain the link between eBL and holo-endemic
malaria have been recently provided [48,49]. In particular, it has
been shown that chronic infection with Plasmodium parasites in-
duces genomic instability and the expression of enzyme activation-
induced cytidine deaminase promotes Plasmodium-associated B-
cell lymphoma in mice [49]. If these observations are confirmed,
reducing the exposure to Plasmodium falciparum or developing
drugs able to block malaria parasites to induce the deregulated
expression of the activation-induced cytidine deaminase should
significantly decrease the incidence of eBL in young children in
Africa. In addition, the interactions between EBV, malaria and HIV,
and the effect of these interactions on the incidence of B-cell
lymphoma in Africa will have to be further elucidated [10].HHV-8 co-infection with Plasmodium falciparum and with
helminth
HHV-8 (after a long period of asymptomatic chronic infection)
causes KS, which manifests itself in four clinical forms: classic KS, a
rare disease of the elderly; endemic KS which mainly affects chil-
dren in sub-Saharan Africa and was well documented before the
explosion of the HIV epidemic; AIDS-associated KS, and iatrogenic
KS associated with immunodepression, such as that observed in
solid organ transplant patients [50,51]. Furthermore, HHV-8 has
been associated with primary effusion lymphoma and multicentric
Castleman's disease, a lymphoproliferative disorder [50,51]. As
other herpesviruses, HHV-8 escapes the host immune control
during all the phases of the infection (primary infection, latency
and reactivation). The host uses the innate and the adaptive im-
mune systems to defend itself from the infection [51].
Chronic herpesvirus infection might have a protective effect
against viral and bacterial infections [36]. In contrast, helminth co-
infection stimulates the replication of g-herpesviruses (murine g-
herpesvirus-68 and HHV-8) [52,53]. The study of Reese [52] and
Osborn et al. [53] expands our perspectives on the complexity of
infectious diseases, showing that members of the gut microbiome,
such as helminthic worms, in addition to bacteria, have relevant
effects on intestinal antiviral immunity and possibly on public
health in tropical medicine [54]. The above-mentioned studies
show that viruses (virome) interact with helminths, generating a
trans-kingdom interaction [6,8], allowing speculation that chronic
herpesvirus infection in humans evolved in the context of co-
infections.
Several epidemiological studies have shown that seropreva-
lence to HHV-8 has been associated with hookworm and in
particular with malaria in sub-Saharan African countries [55e58].
The latter finding might be explained by the fact that repeated
malarial infections can induce HHV-8 reactivation and might
modify the infectivity and/or transmission of HHV-8 [56,58].
Therefore, based on the detection of a high prevalence of HHV-8
infection in areas where malaria is endemic, malaria has been
proposed as a co-factor for the transmission or reactivation of HHV-
8 infection [55e59].
However, HHV-8 co-infection with HIV remains one of the most
significant factors associated with the progression and develop-
ment of KS (reviewed in ref. [9]).
Conclusions
The asymptomatic chronic viral infections are part of the
virome, that includes diseases and physiological effects. In partic-
ular, chronic herpesvirus infections are multifactorial infections
arising from complex interactions among the herpesviruses, host
factors, co-infections and other unknown aspects. Given the fact
that the combinations of host, microbe and environment can
happen in any hostemicrobe interaction, it has been proposed to
dynamically adapt Koch's postulates adding the new findings on
hostemicrobe relationship and microbial interactions [12,60].
Nowadays, the approach to understanding the pathogenesis of
viral infections studying a single virus that interacts with a single
host is too limited to explain the complexity of the relationships
between host and viruses [61]. For example, while evaluating the
virome composition in the blood of solid organ transplant recipients,
it was found that the decline and control of anellovirus replication
might be considered as an indicator of immunocompetence [62].
The reasons why some individuals will develop symptomatic viral
infections are not fully acknowledged at present. Future studies
should combine metagenomic, metatranscriptomic and meta-
proteomic analyses, allowing a better comprehension of the
G. Gentile, A. Micozzi / Clinical Microbiology and Infection 22 (2016) 585e588588pathways and interactions of the viruses and their role on the effects
of chronic asymptomatic infections on human health and diseases.
Transparency declaration
The authors declare that they have no conflicts of interest.
Acknowledgement
We thank Maura Di Pietrantonio for the English revision.
References
[1] Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell
2009;138:30e50.
[2] Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA,
Weinstock GM. Metagenomic analysis of double-stranded DNA viruses in
healthy adults. BMC Biol 2014;10(12):71.
[3] Bernardin F, Operskalski E, Busch M, Delwart E. Transfusion transmission of
highly prevalent commensal human viruses. Transfusion 2010;50:2474e83.
[4] Suk-Fong Lok A. Hepatitis B: 50 years after the discovery of Australia antigen.
J Viral Hepat 2016;23:5e14.
[5] Cho I, Blaser MJ. The human microbiome at the interface of health and disease.
Nat Rev Genet 2012;13:260e70.
[6] Virgin HW. The virome in mammalian physiology and disease. Cell 2014;157:
142e50.
[7] Hooper LV, Littman DR, Macpherson AJ. Interaction between the microbiota
and the immune system. Science 2012;336:1268e73.
[8] Cadwell K. The virome in host health and disease. Immunity 2015;42:805e13.
[9] Thakker S, Verma SC. Co-infections and pathogenesis of KSHV-associated
malignancies. Front Microbiol 2016;7:151.
[10] Rickinson AB. Co-infections, inflammation and oncogenesis: future directions
for EBV research. Semin Cancer Biol 2014;26:99e115.
[11] Reese TA. Co-infections: another variable in the herpesvirus latency-
reactivation dynamic. J Virol 2016;90:5534e7.
[12] Byrd AL, Segre JA. Adapting Koch's postulates. Science 2016;351:224e6.
[13] Koch R. Zer Untersuchung van pathogen organismen: Mittheil. Kais.
Gesundheitsamte 1881;1:1e48.
[14] Henle J, Rosen G. Jacob Henle on miasmata and contagia. Baltimore: The Johns
Hopkins Press; 1938.
[15] Evans AS. Causation and disease: a chronological journey. Am J Epidemiol
1978;108:249e58.
[16] Pierangeli A, Antonelli G, Gentile G. Immunodeficiency-associated viral
oncogenesis. Clin Microbiol Infect 2015;21:975e83.
[17] Hill AB. Environment and disease: association of causation. Proc R Soc Med
1965;58:295e300.
[18] Moore PS, Chang Y. The conundrum of causality in tumor virology: the cases
of KSHV and MCV. Semin Cancer Biol 2014;26:4e12.
[19] White MK, Pagano J, Khalili K. Viruses and human cancers: a long road of
discovery of molecular paradigms. Clin Microbiol Rev 2014;27:463e81.
[20] Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell 2011;147:
44e56.
[21] Cox MJ, Cookson WO, Moffatt MF. Sequencing the human microbiome in
health and disease. Hum Mol Genet 2013;22:R88e94.
[22] Mulcahy-O'Grady H, Workentine ML. The challenge and potential of meta-
genomics in the clinic. Front Immunol 2016;7:29.
[23] Wylie KM, Weinstock GM, Storch GA. Virome genomics: a tool for defining the
human virome. Curr Opin Microbiol 2013;16:479e84.
[24] Bikel S, Valdez-Lara A, Cornejo-Granados F, Rico K, Canizales-Quinteros S,
Soberon X, et al. Combining metagenomics, metatranscriptomics and viromics
to explore novel microbial interactions: towards a systems-level understanding
of human microbiome. Comput Struct Biotechnol J 2015;13:390e401.
[25] GentileG,MeleA,RagonaG,FaggioniA,ZompettaC,TostiME, etal.Humanherpes
virus-6 seroprevalence and leukaemias: a case-control study. GIMEMA (Gruppo
Italiano Malattie Ematologiche dell'Adulto. Br J Cancer 1999;80:1103e6.
[26] Razonable RR. Human herpesviruses 6,7 and 8 in solid organ transplant re-
cipients. Am J Transplant 2013;13(S3):67e78.
[27] Agut H. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-
6) infections. J Clin Virol 2011;52:164e71.
[28] Amon W, Farrell PJ. Reactivation of EpsteineBarr virus from latency. Rev Med
Virol 2005;15:149e56.
[29] Gorres KL, Daigle D, Mohanram S, Miller G. Activation and repression of
EpsteineBarr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles
by short- and medium-chain fatty acids. J Virol 2014;88:8028e44.
[30] Doolittle JM, Webster-Cyriaque J. Polymicrobial infection and bacterium-
mediated epigenetic modification of DNA tumor viruses contribute to path-
ogenesis. Mbio 2014;5:e01015-14.
[31] Morris TL, Arnold RR, Webster-Cyriaque J. Signaling cascades triggered by
bacterial metabolic end products during reactivation of Kaposi's sarcoma-
associated herpesvirus. J Virol 2007;81:6032e42.[32] Imai K, Inoue H, TamuraM, CuenoME, Inoue H, Takeichi O, et al. The periodontal
pathogen Porphyromonas gingivalis induces the EpsteineBarr virus lytic switch
transactivator ZEBRA by histone modification. Biochimie 2012;94:839e46.
[33] Gentile G, Antonelli G. Interplay between B herpesviruses and fungal in-
fections in transplant patients: from the bench to bedside. Future Virol
2015;10:399e414.
[34] Gentile G. Post-transplant HHV-6 diseases. Herpes 2000;7:24e7.
[35] GentileG, CapobianchiA, FerraironiM,GrecoE,MartinoP. Relationshipof serum
human herpesvirus 6 DNA with cytomegalovirus pp65 antigenemia in alloge-
neic bone marrow transplant recipients. Transplantation 2004;77:1907e8.
[36] Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS,
et al. Herpesvirus latency confers symbiotic protection from bacterial infec-
tion. Nature 2007;447:326e9.
[37] Raffegerst S, Steer B, Hohloch M, Adler H. Prevention of tumor formation by
latent gammaherpesvirus infection. PLoSOne 2015;10:e0145678.
[38] Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJ, Onengut-Gumuscu S, et al.
Cytomegalovirus infection enhances the immune response to influenza. Sci
Transl Med 2015;7:281ra43.
[39] Onyeagocha C, Hossain MS, Kumar A, Jones RM, Roback J, Gewirtz AT. Latent
cytomegalovirus infection exacerbates experimental colitis. Am J Pathol
2009;175:2034e42.
[40] Balfour HH, Dunmire SK, Hogquist KA. Infectious mononucleosis. Clin Transl
Immunol 2015;4:e33.
[41] Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, et al.
Early age at time of primary EpsteineBarr virus infection results in poorly
controlled viral infection in infants from Western Kenya: clues to the etiology
of endemic Burkitt lymphoma. J Infect Dis 2012;205:906e13.
[42] Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R.
Spatial distribution of Burkitt's lymphoma in Kenya and association with
malaria risk. Trop Med Int Health 2007;12:936e43.
[43] Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann A. Does EBV alter the
pathogenesis of malaria? Parasite Immunol 2015;37:433e45.
[44] Schmidt CQ, Kennedy AT, Tham WH. More than just immune evasion:
Hijacking complement by Plasmodium falciparum. Mol Immunol 2015;67:
71e84.
[45] de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, et al. Epidemio-
logical evidence for causal relationship between EpsteineBarr virus and
Burkitt's lymphoma from Ugandan prospective study. Nature 1978;274:
756e61.
[46] Reynaldi A, Schlub TE, Chelimo K, Sumba PO, Piriou E, Ogolla S, et al. Impact of
Plasmodium falciparum coinfection on longitudinal EpsteineBarr virus kinetics
in Kenyan children. J Infect Dis 2016;213:985e91.
[47] Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromo-
somal translocations in healthy individuals. Genes Chromosomes Cancer
2003;36:211e23.
[48] Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA.
A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma
pathogenesis. PLoS Pathog 2014;10:e1004170.
[49] Robbiani DF, Deroubaix S, Feldhahn N, Oliveira TY, Callen E, Wang Q, et al.
Plasmodium infection promotes genomic instability and AID-dependent B cell
lymphoma. Cell 2015;162:727e37.
[50] Schulz TF, Cesarman E. Kaposi sarcoma-associated herpesvirus: mechanisms
of oncogenesis. Curr Opin Virol 2015;14:116e28.
[51] Dittmer DP, Damania B. Kaposi sarcoma associated herpesvirus pathogenesis
(KSHV)- an update. Curr Opin Virol 2013;3:238e44.
[52] Reese TA, Wakeman BS, Choi HS, Hufford MM, Huang SC, Zhang X, et al.
Helminth infection reactivates latent g-herpesvirus via cytokine competition
at a viral promoter. Science 2014;345:573e7.
[53] Osborne LC, Monticelli LA, Nice TJ, Sutherland TE, Siracusa MC, Hepworth MR,
et al. Coinfection. Virusehelminth coinfection reveals a microbiota-
independent mechanism of immunomodulation. Science 2014;345:578e82.
[54] Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al.
Control of neglected tropical diseases. N Engl J Med 2007;357:1018e27.
[55] Wakeham K, Webb EL, Sebina I, Muhangi L, Miley W, Johnson WT, et al.
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus
(KSHV) in Ugandan women. Infect Agent Cancer 2011;6:15.
[56] Wakeham K, Webb EL, Sebina I, Nalwoga A, Muhangi L, Miley WJ, et al. Risk
factors for seropositivity to Kaposi sarcoma-associated herpesvirus among
children in Uganda. J Acquir Immune Defic Syndr 2013;63:228e33.
[57] Nascimento MC. Malaria may influence the transmission of Kaposi sarcoma
associated herpesvirus in endemic areas. J Acquir Immune Defic Syndr
2014;67:e41e3.
[58] Nalwoga A, Cose S, Wakeham K, Miley W, Ndibazza J, Drakeley C, et al. As-
sociation between malaria exposure and Kaposi's sarcoma-associated herpes
virus seropositivity in Uganda. Trop Med Int Health 2015;20:665e72.
[59] Stolka K, Ndom P, Hemingway-Foday J, Iriondo-Perez J, Miley W, Labo N, et al.
Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case
control study in Cameroon. Cancer Epidemiol 2014;38:137e43.
[60] Casadevall A, Pirofski L. What is a host? Incorporating the microbiota into the
damage-response framework. Infect Immun 2015;83:2e7.
[61] Pfeiffer JK, Virgin HW. Viral immunity. Transkingdom control of viral infection
and immunity in the mammalian intestine. Science 2016;351(6270).
[62] De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal
response of the human virome to immunosuppression and antiviral therapy.
Cell 2013;155:1178e87.
